08.16.2017
Prevent & Delay
$23,171,604.00
60 months
The GPPAD-02 Study: Identification of Infants with High Risk of Type 1 Diabetes for Primary Prevention
Funding Helmholtz Zentrum München to support a multinational, European system to perform primary prevention clinical trials for type 1 diabetes.